0001012975-19-000254.txt : 20190401
0001012975-19-000254.hdr.sgml : 20190401
20190401173514
ACCESSION NUMBER: 0001012975-19-000254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190401
DATE AS OF CHANGE: 20190401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOODMAN COREY S
CENTRAL INDEX KEY: 0001278411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19722047
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adelman Robert J
CENTRAL INDEX KEY: 0001329161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19722048
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, Ltd.
CENTRAL INDEX KEY: 0001770835
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19722049
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic GP, L.P.
CENTRAL INDEX KEY: 0001770834
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19722050
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: venBio Global Strategic Fund, L.P.
CENTRAL INDEX KEY: 0001504130
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38841
FILM NUMBER: 19722051
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-522-0100
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET, SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRECISION BIOSCIENCES INC
CENTRAL INDEX KEY: 0001357874
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-314-5512
MAIL ADDRESS:
STREET 1: 302 EAST PETTIGREW STREET
STREET 2: SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-04-01
1
0001357874
PRECISION BIOSCIENCES INC
DTIL
0001504130
venBio Global Strategic Fund, L.P.
C/O VENBIO PARTNERS, LLC
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
1
0
1
0
0001770834
venBio Global Strategic GP, L.P.
C/O VENBIO PARTNERS, LLC
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001770835
venBio Global Strategic GP, Ltd.
C/O VENBIO PARTNERS, LLC
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
0001329161
Adelman Robert J
C/O VENBIO PARTNERS, LLC
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
1
0
1
0
0001278411
GOODMAN COREY S
C/O VENBIO PARTNERS, LLC
1700 OWENS STREET, SUITE 595
SAN FRANCISCO
CA
94158
0
0
1
0
Common Stock
2019-04-01
4
P
0
50000
16.00
A
50000
I
See footnote
Common Stock
2019-04-01
4
C
0
3747623
A
3797623
I
See footnote
Common Stock
2019-04-01
4
C
0
467518
A
4265141
I
See footnote
Series A Preferred Stock
2019-04-01
4
C
0
8000000
0
D
Common Stock
3747623
0
I
See footnote
Series B Preferred Stock
2019-04-01
4
C
0
998004
0
D
Common Stock
467518
0
I
See footnote
Each share of the Issuer's preferred stock converted into shares of the Issuer's common stock, $0.000005 par value per share, on a one-for-2.134686 basis upon the closing of the Issuer's initial public offering, after giving effect to the reverse stock split effected by the Issuer in connection with the initial public offering.
venBio Global Strategic GP, LP is the sole general partner of venBio Global Strategic Fund, LP and venBio Global Strategic GP, Ltd. is the sole general partner of venBio Global Strategic GP, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.
venBio Global Strategic Fund, LP, by: venBio Global Strategic GP, LP, its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact
2019-04-01
venBio Global Strategic GP, LP, its general partner, by: venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact
2019-04-01
venBio Global Strategic GP, Ltd., its general partner, by: /s/ Dave Pezeshki, Attorney-in-Fact
2019-04-01
Robert Adelman, by: /s/ Dave Pezeshki, Attorney-in-Fact
2019-04-01
Corey Goodman, by: /s/ Dave Pezeshki, Attorney-in-Fact
2019-04-01